Tezepelumab Injection Uses, Dosage, Side Effects and Interactions
Tezspire
Tezspire was the first tezepelumab injection product the FDA approved, in 2021.
Tezepelumab Injection is a once-monthly add-on biologic medicine for severe asthma and for chronic rhinosinusitis with nasal polyps (nasal polyps with long-lasting sinus inflammation) in people 12 and older.
Quick links
Ask Anything About Tezepelumab InjectionType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Tezepelumab Injection in Short
- Drug class Thymic Stromal Lymphopoietin Blocker How the FDA classifies it
What it treatsTezepelumab Injection (brand name TEZSPIRE) is an add-on maintenance treatment. It is used along with your other regular treatments, not in place of them. TEZSPIRE is used for severe asthma and for inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adults and children aged 12 and older.
- How you get it Prescription only
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs52 interact 51 moderate and 1 minor, none major
The Pharmacist’s Take
Tezepelumab (Tezspire) is one of the newer biologic injections, prescribed by specialists and on the U.S. market since about 2021, added on to regular treatment for severe asthma and for chronic sinusitis with nasal polyps in people 12 and older. It works by blocking TSLP, an early signal that sets off airway inflammation, which lowers markers such as eosinophils (allergy-type white blood cells). Most people tolerate it well, and what they notice is usually a sore throat, cold-like symptoms, joint or back pain, or redness where the shot went in. Watch for an allergic reaction, which can appear hours or even days after a shot, and get emergency help for swelling or trouble breathing.
Key Takeaways From the HelloPharmacist Team
- Expect a shot under the skin every 4 weeks, given at the clinic or at home, as your prescriber decides.
- Keep carrying your rescue inhaler, because tezepelumab works over time to prevent flare-ups and does nothing for a sudden asthma attack.
- Do not cut back or stop steroid medicines on your own, since any reduction should be gradual and supervised by your doctor.
- Avoid live vaccines while you are on it, and check with your prescriber before getting any vaccine.
Tezepelumab Injection by the Numbers
- Earliest FDA record
- 2021
- Rank by Medicaid prescriptions
- #673 of 1,666 drugs
- More prescriptions than 59% of the 1,666 drugs we measure
- 42,607 prescriptions, Q1–Q4 2025
Patient Information Guide for Tezepelumab Injection
What It’s Used For
Tezepelumab Injection (TEZSPIRE) is an add-on maintenance treatment for:
- Severe asthma in adults and children 12 and older. It is not for acute bronchospasm or status asthmaticus.
- Inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adults and children 12 and older.
How It Works
Tezepelumab is a human monoclonal antibody (a lab-made protein). It binds to TSLP, a protein from airway and nasal lining cells that sits high in the inflammation chain. Blocking TSLP lowers inflammation markers such as blood eosinophils, IgE, FeNO, IL-5 and IL-13.
The exact way it works in asthma and nasal polyps has not been definitively established.
Drug Class
Drug Class
- Thymic Stromal Lymphopoietin Blocker
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Thymic Stromal Lymphopoietin Blocker
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Thymic Stromal Lymphopoietin Blockers
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Tezepelumab Injection in the FDA’s index.
From our Patient Information GuideTezepelumab is a human monoclonal antibody (a lab-made protein). It binds to TSLP, a protein from airway and nasal lining cells that sits high in the inflammation chain. Read How Tezepelumab Injection Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Tezepelumab Injection in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other systemic drugs for obstructive airway diseases
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
TEZSPIRE is injected under the skin once every 4 weeks.
- The vial and pre-filled syringe are given by a healthcare provider.
- The pre-filled pen can be used by patients or caregivers after training, if the provider agrees.
- Injection sites are the thigh or abdomen (not within 2 inches of the navel). A provider or caregiver may also use the upper arm. Rotate sites.
- Let it warm to room temperature (about 60 minutes). Do not shake it or put it back in the fridge.
- If you miss a dose, give it as soon as possible, then go back to your usual schedule.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Severe asthma (add-on maintenance treatment)
For adults and children 12 years and older
Usual dose 210 mg once every 4 weeks
- 210 mg administered subcutaneously once every 4 weeks
Chronic stuffy, swollen sinuses with nasal polyps (add-on maintenance treatment)
For adults and children 12 years and older
Usual dose 210 mg once every 4 weeks
- 210 mg administered subcutaneously once every 4 weeks
Good to Know for Every Dose
If a dose is missed, administer as soon as possible, then resume the usual day of administration; if the next dose is already due, administer as planned
Side Effects
Common side effects seen in studies include:
Common side effects
- Sore throat (pharyngitis)
- Joint pain (arthralgia)
- Back pain
- Stuffy or runny nose and throat irritation (nasopharyngitis)
- Upper respiratory infection
- Nosebleeds (epistaxis)
- Flu
- Injection site reactions such as redness, swelling or pain
When to get medical help
- Get emergency help for signs of a severe allergic reaction (anaphylaxis). These can happen within hours, or sometimes days later.
- Call your doctor if you develop a rash or red, itchy eyes (allergic conjunctivitis) after an injection.
- Call your doctor if your asthma stays uncontrolled or gets worse during treatment.
- Call your doctor if you develop a parasitic worm infection that does not improve with treatment.
- Do not use TEZSPIRE to treat a sudden asthma attack. Get urgent medical help for one.
Warnings and Precautions
- Allergic reactions: rash, allergic conjunctivitis and anaphylaxis have occurred, sometimes days after the dose.
- Not a rescue medicine: do not use it for sudden asthma symptoms. Seek medical advice if asthma worsens.
- Steroids: do not stop them abruptly. Reduce gradually under a doctor's supervision.
- Parasitic infections: treat existing worm infections first.
- Vaccines: avoid live attenuated vaccines.
- Heart events: a long-term asthma study found more serious cardiac events with TEZSPIRE than placebo, of varied types.
Interactions
No formal drug interaction studies have been done.
- Live attenuated vaccines: use has not been evaluated and should be avoided.
- Steroids: do not stop suddenly when starting TEZSPIRE.
- Leukotriene receptor antagonists, theophylline or aminophylline, and oral or inhaled corticosteroids did not meaningfully change tezepelumab clearance.
Interactions Listed in the FDA-Approved Label
From the Tezepelumab Injection prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
No formal drug interaction studies have been performed with TEZSPIRE.
Read the label’s full interactions text
7 DRUG INTERACTIONS No formal drug interaction studies have been performed with TEZSPIRE.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if you are allergic to tezepelumab-ekko or any of its ingredients.
- Tell your doctor about any parasitic worm infection.
- Pregnancy: there are no human data. Uncontrolled asthma also carries risks in pregnancy.
- Breastfeeding: effects on infants are unknown, so discuss it with your doctor.
- Children: not established under 12.
- Older adults: no overall differences in safety or effectiveness.
- Kidney: not studied in severe kidney impairment. Mild to moderate impairment did not change clearance.
- Liver: no formal studies, and changes in liver function are not expected to affect clearance.
Half-Life and How Your Body Processes It
After injection under the skin, blood levels peak in about 3 to 10 days. About 77% of the dose is absorbed. Steady levels are reached after about 12 weeks of every-4-week dosing. It is broken down by the body's ordinary protein-clearing enzymes rather than liver enzymes, and its half-life is about 26 days. Age, sex and race did not meaningfully affect it. Higher body weight lowered exposure but did not require dose changes.
Storage
Store refrigerated between 36°F to 46°F (2°C to 8°C). Refrigerator once TEZSPIRE has reached room temperature. Refrigerator, TEZSPIRE must be used within 30 days or discarded.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Tezepelumab Injection
From the licensed clinical database we use, rolled up per supplement, most serious first.52 supplements and herbal products have documented interactions with Tezepelumab Injection in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 51Moderate
- 1Minor
- ACTIVE HEXOSE CORRELATED COMPOUND (AHCC)Moderate
- ALFALFAModerate
- AMERICAN GINSENGModerate
- ANDROGRAPHISModerate
- ASHWAGANDHAModerate
- ASTRAGALUSModerate
- BEE VENOMModerate
- BETA-GLUCANSModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Tezepelumab Injection: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Tezepelumab Injection — the kind of thing our pharmacy team would talk through with you at the counter.
What is tezepelumab injection used for?
What happens if I miss a dose of tezepelumab injection?
Can I stop my steroid medicines when I start tezepelumab injection?
What side effects should I expect with tezepelumab injection?
Can I get vaccines while taking tezepelumab injection?
Can I give myself tezepelumab injection at home?
Is tezepelumab injection available over the counter?
When was tezepelumab injection first available?
What is the brand name of tezepelumab injection?
What is the generic name of Tezspire?
What drug class is tezepelumab injection?
Where can I read the tezepelumab injection prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Tezepelumab Injection
Skip the scrolling. Ask in your own words and get an answer from Tezepelumab Injection’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Tezepelumab Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Tezepelumab Injection on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Tezepelumab Injection on the U.S. Market: Products, Makers and Brands
How Tezepelumab Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
The FDA lists Tezepelumab Injection products; the earliest marketing or approval year on record is 2021.
How Widely Tezepelumab Injection Is Used (Medicaid Data)
How many Tezepelumab Injection prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Tezepelumab Injection prescribed? Of the 1,666 medications we measure, Tezepelumab Injection ranks #673 by Medicaid prescriptions — more than 60% of them.
Utilization by Tezepelumab Injection product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
1.91 ML tezepelumab-ekko 110 MG/ML Auto-Injector Most dispensed
1 of 2 listed NDCs had Medicaid claims. RxNorm 2628920
1.91 ML tezepelumab-ekko 110 MG/ML Prefilled Syringe
1 of 3 listed NDCs had Medicaid claims. RxNorm 2587803
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 2 of the 5 listed Tezepelumab Injection NDCs had Medicaid claims.
Tezepelumab Injection Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Tezepelumab Injection — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Tezepelumab Injection are asthma, dyspnoea, arthralgia; about 45% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Tezepelumab Injection in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Tezepelumab Injection FDA Approval History
How Tezepelumab Injection went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Tezepelumab Injection was first approved by the FDA in 2021 (Brand: TEZSPIRE · Astrazeneca Ab). It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Tezepelumab Injection Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Tezepelumab recalls since July 2021.
✅No Tezepelumab recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 12, 2026.
Tezepelumab Injection in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 2
- Strengths
- 2
- Forms in current FDA listings
- 0 of 2
RxCUI 2587789 -
Dose form (SCDF) Auto-InjectorNo current FDA listing
RxCUI 2628919Its strength (SCD)-
1.91 mL tezepelumab-ekko 110 mg/mL
RxCUI 2628920
-
1.91 mL tezepelumab-ekko 110 mg/mL
-
Dose form (SCDF) Prefilled SyringeNo current FDA listing
RxCUI 2587802Its strength (SCD)-
1.91 mL tezepelumab-ekko 110 mg/mL
RxCUI 2587803
-
1.91 mL tezepelumab-ekko 110 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Tezepelumab Injection Supply and Shortage Status
Whether Tezepelumab Injection is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Tezepelumab Injection Brand Names
Tezepelumab Injection has one brand name on record: Tezspire. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Sources for This Tezepelumab Injection Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Amgen, Inc is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →